Shawcross DL - Search Results

1

Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?

Shawcross DL. Shawcross DL. Expert Rev Gastroenterol Hepatol. 2015 May;9(5):539-42. doi: 10.1586/17474124.2015.1035257. Epub 2015 Apr 6. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25846450

2

The molecular pathogenesis of hepatic encephalopathy.

Jalan R, Shawcross D, Davies N. Jalan R, et al. Int J Biochem Cell Biol. 2003 Aug;35(8):1175-81. doi: 10.1016/s1357-2725(02)00396-5. Int J Biochem Cell Biol. 2003. PMID: 12757755 Review.

3

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

Shawcross DL, Davies NA, Williams R, Jalan R. Shawcross DL, et al. J Hepatol. 2004 Feb;40(2):247-54. doi: 10.1016/j.jhep.2003.10.016. J Hepatol. 2004. PMID: 14739095 Free article.

4

Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy.

Shawcross DL, Davies NA, Mookerjee RP, Hayes PC, Williams R, Lee A, Jalan R. Shawcross DL, et al. Hepatology. 2004 Feb;39(2):471-5. doi: 10.1002/hep.20044. Hepatology. 2004. PMID: 14768000 Clinical Trial.

5

Ammonia and hepatic encephalopathy: the more things change, the more they remain the same.

Shawcross DL, Olde Damink SW, Butterworth RF, Jalan R. Shawcross DL, et al. Metab Brain Dis. 2005 Sep;20(3):169-79. doi: 10.1007/s11011-005-7205-0. Metab Brain Dis. 2005. PMID: 16167195 Review.

6

Role of ammonia and inflammation in minimal hepatic encephalopathy.

Shawcross DL, Wright G, Olde Damink SW, Jalan R. Shawcross DL, et al. Metab Brain Dis. 2007 Mar;22(1):125-38. doi: 10.1007/s11011-006-9042-1. Metab Brain Dis. 2007. PMID: 17260161 Clinical Trial.

7

Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.

Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Shawcross DL, et al. Hepatology. 2010 Mar;51(3):1062-9. doi: 10.1002/hep.23367. Hepatology. 2010. PMID: 19890967 Review.

8

Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.

Shawcross DL, Sharifi Y, Canavan JB, Yeoman AD, Abeles RD, Taylor NJ, Auzinger G, Bernal W, Wendon JA. Shawcross DL, et al. J Hepatol. 2011 Apr;54(4):640-9. doi: 10.1016/j.jhep.2010.07.045. Epub 2010 Dec 1. J Hepatol. 2011. PMID: 21163546

9

Systemic inflammation and ammonia in hepatic encephalopathy.

Tranah TH, Vijay GK, Ryan JM, Shawcross DL. Tranah TH, et al. Among authors: shawcross dl. Metab Brain Dis. 2013 Mar;28(1):1-5. doi: 10.1007/s11011-012-9370-2. Epub 2012 Dec 7. Metab Brain Dis. 2013. PMID: 23224356 Review.

10

Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy.

Kok B, Foxton MR, Clough C, Shawcross DL. Kok B, et al. Among authors: shawcross dl. Hepatology. 2013 Oct;58(4):1516-7. doi: 10.1002/hep.26364. Epub 2013 Aug 22. Hepatology. 2013. PMID: 23471844 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page